EllisNeufeldMDPhD, FAAP

Hematology • Memphis, TN

Clotting Disorder, Hemophilia & Bleeding Disorder, Sickle Cell & Other Anemias

Clinical Director, EVP and Physician-in-Chief, St. Jude Children's Research Hospital

Join to view full profile

Dr. Neufeld is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Neufeld's full profile

Already have an account?

Office
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105

Clinical Expertise

Thalassemias, Immune thrombocytopenic purpura, Deep vein thrombosis, Hemophilia, Thrombotic disorders, Hospital administration, Genetic blood disorders, Iron overload

Education & Training

Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1988 - 1990
Boston Children’s Hospital/Harvard Medical SchoolFellowship, Medical Genetics and Genomics, 1988 - 1988
Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1986 - 1988
Boston Children’s Hospital/Boston Medical CenterInternship, Pediatrics, 1985 - 1986
Washington University in St. Louis School of MedicineClass of 1985

Certifications & Licensure

TN State Medical License 2017 - 2026
MA State Medical License 1987 - 2025
FL State Medical License 2015 - 2017
American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

William Hathaway Visiting Professor Denver Children's Hospital, 2012
Abelson Visiting Professor Washington University School of Medicine, 2012
Coopersmith Visiting Professor John's Hopkins University, 2012
National President's Award Cooley's Anemia Foundation, 2011
Elected Member The American Society for Clinical Investigation, 2003
Join now to see all

Clinical Trials

Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN) Start of enrollment: 2000 Jul 01
Completed
Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases Start of enrollment: 2005 Jun 01
Terminated
Phase 2
Optimal Platelet Dose Strategy for Management of Thrombocytopenia Start of enrollment: 2004 Jul 01
Completed
Phase 3
Rituximab to Treat Severe Hemophilia A Start of enrollment: 2006 Jun 01
Completed
Phase 2
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study) Start of enrollment: 2008 Jan 01
Terminated
Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study) Start of enrollment: 2008 Apr 01
Completed
Phase 3
Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) Study Start of enrollment: 2007 May 01
Completed
Evaluating the Effectiveness of Adding Rituximab to Standard Treatment for Thrombotic Thrombocytopenic Purpura (TTP) Start of enrollment: 2009 Apr 01
Terminated
Phase 3
Sildenafil to Improve Exercise Capacity in People With Thalassemia and Pulmonary Hypertension Start of enrollment: 2009 Mar 01
Completed
Phase 2, Phase 3
Assessment of Pain in People With Thalassemia Start of enrollment: 2009 Mar 01
Completed
Initial Treatment of Patients With Immune Thrombocytopenic Purpura Start of enrollment: 2010 Jan 01
Terminated
Phase 3
Efficacy of Vorinostat to Induce Fetal Hemoglobin in Sickle Cell Disease Start of enrollment: 2009 Oct 01
Terminated
Phase 2
Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron Overload Start of enrollment: 2009 Nov 01
Completed
Phase 1
Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study Start of enrollment: 2010 Jun 01
Completed
Safety and Pharmacodynamic Study of an Oral Iron Chelator Given for 6 Months to Patients With Iron Overload Start of enrollment: 2010 Aug 13
Completed
Phase 2
Pilot Phase I/II Study of Amino Acid Leucine in Treatment of Patients With Transfusion-Dependent Diamond Blackfan Anemia Start of enrollment: 2013 Jun 01
Completed
Phase 1, Phase 2
A Phase II Trial of Regadenoson in Sickle Cell Anemia Start of enrollment: 2013 Jul 01
Completed
Phase 2
ATHN 2: Factor Switching Study Start of enrollment: 2015 Sep 01
Completed
Join now to see all

Publications & Presentations

PubMed

Genetic variants in canonical Wnt signaling pathway associated with pediatric immune thrombocytopenia.
Taylor Olmsted Kim, Jennifer M Geris, Jonathan M Flanagan, Rachael F Grace, Michele P Lambert
Blood Advances. 2024-11-12
Which pediatric ITP patients will go on to lupus?
Ellis J Neufeld
Blood. 2024-04-18
Diagnosis and management of pyruvate kinase deficiency: international expert guidelines.
Hanny Al-Samkari, Nadine Shehata, Kelly Lang-Robertson, Paola Bianchi, Andreas Glenthøj
The Lancet. Haematology. 2024-03-01

Abstracts/Posters

Inhibitor Development with Simoctocog Alfa in Previously Untreated Patients with Severe Haemophilia a: Final Results of the Nuprotect Study
Ellis J. Neufeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency
Ellis J. Neufeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Lack of Inhibitor Development in the American Thrombosis and Hemostasis Network (ATHN)-2 Factor Switching Study: Preliminary Report of Primary Outcome
Ellis J. Neufeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
A Phase 3 Study of Eltrombopag Vs. Standard First-Line Management for Newly Diagnosed Immune Thrombocytopenia in Children
Ellis J. Neufeld, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Join now to see all

Lectures

Navigating Immune Thrombocytopenic Purpura Treatment in 2018: Expert Perspectives on the Latest Advances
60th American Society of Hematology Annual Meeting - 11/30/2018
2011 ASH Annual Meeting and Exposition
American Society of Hematology (ASH), San Diego, California - 12/10/2011

Press Mentions

U.S. News Ranks Two Memphis Children's Hospitals Among Nation's BestJune 14th, 2022
COVID-19 Vaccine Is Associated with Fewer Asymptomatic SARS-CoV-2 Infections, Study FindsMay 6th, 2021
Vioxx, Once Vilified like Thalidomide, May Also Return to the MarketOctober 10th, 2019
Join now to see all